Search Results

Your search for Eduardo Bruera, MD matches 3 pages

Showing 1 - 3

By Matthew Stenger / Thursday, October 26, 2017 9:24 AM

Changes in Opioid Prescription for Cancer Patients Referred to Outpatient Palliative Care

In a study reported in the Journal of Oncology Practice, Haider et al found that the median morphine equivalent daily dose decreased significantly among cancer patients seen at MD Anderson Cancer Center’s outpatient palliative care clinic between 2010 and 2015. Use of hydrocodone decreased...

palliative care

pain management

supportive care

By The ASCO Post Staff / 2016 Palliative Care in Oncology Symposium

Eduardo Bruera, MD, on Managing Opioid Use in Patients With a History of Addiction

Eduardo Bruera, MD, of The University of Texas MD Anderson Cancer Center, discusses the need for outpatient palliative care programs to monitor and support these complex patients and their family members.

palliative care

symptom management

By Eduardo Bruera, MD / 2015 Palliative Care in Oncology Symposium

Eduardo Bruera, MD, on Cachexia Assessment and Management State of the Art

Eduardo Bruera, MD, of The University of Texas MD Anderson Cancer Center, discusses exciting developments in the assessment and management of cachexia, as well as a number of emerging pharmacologic and nonpharmacologic interventions (Abstract 67).

Apr

Today In Oncology

Search Results

Your search for Eduardo Bruera, MD matches 3 pages

Changes in Opioid Prescription for Cancer Patients Referred to Outpatient Palliative Care

Eduardo Bruera, MD, on Managing Opioid Use in Patients With a History of Addiction

Eduardo Bruera, MD, on Cachexia Assessment and Management State of the Art

FDA Approves Lu-177 Dotatate for Pediatric Patients With GEP-NETs

AI Model May Help Predict Treatment Responses Select Most Effective Cancer Therapies in Patients With Cancer

In-Hospital Mortality Among Patients With COVID-19 Infection, With or Without Cancer

Imaging Drug to Assist in Detection of Cancerous Tissue Following Lumpectomy Approved

Potential Protective Effects of Aspirin Against Colorectal Cancer